Kun Zhang
Direktor/Vorstandsmitglied bei SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Kun Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Direktor/Vorstandsmitglied | 20.04.2018 | - |
| Corporate Officer/Principal | 20.04.2018 | - |
Karriereverlauf von Kun Zhang
Ehemalige bekannte Positionen von Kun Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Essen Technology (Beijing) Co., Ltd.
 Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01.11.2014 | 01.10.2020 |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Vertrieb & Marketing | 01.05.2009 | 01.01.2011 |
| MICROPORT SCIENTIFIC CORPORATION | Vertrieb & Marketing | 01.05.2002 | 01.03.2004 |
Ausbildung von Kun Zhang
| Academy of Armored Forces Engineering | Undergraduate Degree |
| City University of Hong Kong | Masters Business Admin |
Statistik
International
| China | 5 |
| Cayman Islands | 2 |
| Hong Kong | 2 |
Operativ
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| MICROPORT SCIENTIFIC CORPORATION | Health Technology |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Health Technology |